CEBPB and cardiac hypertrophy: Apparently, less fibrosis and cardiomyocyte death in the non-infarct region were also observed in Cebpb-overexpressed group (Figure 6E and F), albeit cardiac hypertrophy remaining akin to control group post-MI (Figure 6G).